Speciality pharma maker of branded generics in India, Asia & Africa, plus US generics and institution sales.
Price
Market Cap
Sector
Healthcare
Rank
| Line item | FY20 | FY21 | FY22 | FY23 | FY24 | FY25 | FY26 | FY26 |
|---|---|---|---|---|---|---|---|---|
| LiabilitiesEquity Capital | 18 | 17 | 17 | 25 | 25 | 25 | 25 | 25 |
| Reserves | 2.6k | 3.0k | 3.2k | 3.4k | 3.5k | 3.8k | 4.3k | 4.5k |
| Borrowings | 75 | 31 | 25 | 36 | 35 | 47 | 246 | 260 |
| Other Liabilities | 619 | 702 | 711 | 1.2k | 927 | 1.1k | 1.1k | 1.3k |
| Total Liabilities | 3.3k | 3.7k | 4.0k | 4.6k | 4.5k | 4.9k | 5.7k | 6.0k |
| AssetsFixed Assets | 1.5k | 1.5k | 1.5k | 1.5k | 1.5k | 1.8k | 1.9k | 1.9k |
| CWIP | 132 | 108 | 153 | 209 | 256 | 176 | 146 | 258 |
| Investments | 79 | 176 | 147 | 535 | 349 | 464 | 874 | 588 |
| Other Assets | 1.6k | 1.9k | 2.2k | 2.3k | 2.4k | 2.5k | 2.8k | 3.3k |
| Total Assets | 3.3k | 3.7k | 4.0k | 4.6k | 4.5k | 4.9k | 5.7k | 6.0k |
The Earnings Per Share over the last 12 months.
Your assumption of the company's expected yearly EPS growth (e.g., 6 for 6%).
Pre-filled with the lower of median (34.6×) and current (36.3×) PE — the conservative anchor.
The annualized return you aim to achieve. We solve for the price that delivers it, then compare to today's price.
At 21.5% growth and a 35× exit, ₹3065 only delivers your return if you pay ₹3,551. The price is currently baking in 18% growth.
EPS grows 21.5%/yr for 5 years, then fades to 6% over 2, exits at 35×.
| Year | Growth | EPS (₹) |
|---|---|---|
| FY27 | 21.5% | 102.70 |
| FY28 | 21.5% | 124.79 |
| FY29 | 21.5% | 151.61 |
| FY30 | 21.5% | 184.21 |
| FY31 | 21.5% | 223.82 |
| FY32 | 13.8% ·fade | 254.59 |
| FY33 | 6.0% ·fade | 269.87 |
Methodology: we discount normalized net profit as a proxy for owner earnings (an earnings-power approximation — not full free cash flow). Terminal growth is capped at 6% (≈ nominal GDP) regardless of the required return. This is an analytical tool, not investment advice.
Guides on how to read this kind of business and the numbers that matter.